STAT NewsOriginal article
STAT+: Definium’s LSD therapy eased anxiety in second large trial
Phase 2positiveLSD therapyPositive
AI Analysis
Summary
Definium's LSD therapy demonstrated positive results in a second large trial for anxiety treatment. The company is part of the first wave of biotechs advancing psychedelic therapies toward regulatory approval.
Clinical Trial Data
Phase
2
Primary Endpoint
Met
Outcome Details
LSD therapy eased anxiety in second large trial
Importance:6/10
Sentiment:
0.70
psychedelicLSDanxietyclinical trialregulatory approval pathway
Read the original article
Published by STAT News on September 14, 2026 11:00 AM